Advanced non-invasive monitoring for individual and patient-adapted anesthesia management

Phase 2

Conditions: Malignant neoplasm of prostate
Malignant neoplasm of liver and intrahepatic bile ducts
Malignant neoplasm of oesophagus
Other peripheral vascular diseases
C25
I74
Malignant neoplasm of kidney, except renal pelvis
Arterial embolism and thrombosis
C26
C22

Registration Number: DRKS00033353

Lead Sponsor: Klinik für Anästhesiologie, operative Intensiv- und Schmerzmedizin Universitätsmedizin Mannheim

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Pending

Sex: All

Target Recruitment: 530

Inclusion Criteria

• ASA class I-IV
• Patients from the aforementioned specific areas
• Signed consent form for participation in the stud

Exclusion Criteria

• Emergency procedures
• Mental impairment that prevents the patient from understanding the nature, extent, and significance of the research project
• Muscular dystrophies, myasthenias
• Cardiac arrhythmia

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Total opioid amount (intraoperative + in the recovery room + during hospitalization) in milligrams, morphine equivalent and<br>Postoperative pain control assessed using the Numerical Rating Scale (NRS) and QUIPS questionnaire.

Secondary Outcome Measures

Name	Time	Method
• Postoperative delirium monitoring / Qualitative awareness assessed using SBI (Sedation-Behavioral-Inventory).<br>• Time to extubation<br>• Postoperative duration of hospital stay<br>• Time in an Intensive Care Unit / Intermediate Care Unit (IMC)<br>• Noradrenaline requirement in milligrams<br>• Total intravenous infusion volume in milliliters<br>• Crystalloids in milliliters<br>• Colloids in milliliters<br>• Transfusions (PRBC, FFP, Platelets) in milliliters<br>• Total blood loss in milliliters